Keywords: profits, down, astrazeneca, prilosec, sales, plummet, nexium

Profits down at AstraZeneca as Prilosec sales plummet, but Nexium turnover soars

Article | 05 May 2003

Print This

Anglo-Swedish drugmaker AstraZeneca has posted a 3% decline in pretaxprofits for the first quarter of 2003 as the company began to feel ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in